Market Overview:
The global neohespiridine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for neohespiridine in various applications such as food, medicine, chemical, cosmetics and others. Additionally, rising awareness about the benefits of neohespiridine is also propelling the growth of this market. Some of the key players operating in this market are BASF SE (Germany), Akzo Nobel N.V (Netherlands), Solvay S.A (Belgium) and Evonik Industries AG (Germany).
Product Definition:
A synthetic opioid analgesic that is structurally related to methadone and is used in the treatment of moderate to severe pain.
Industrial Grade:
Industrial grade is also known as Institute or Form Grade. It is a pure form of Epirrita Hesperidinum plant extract used in the treatment of bronchitis and other respiratory disorders. The product has no commercial substitute and it can be easily obtained from any reliable source such as manufacturer, wholesaler or online retailer.
Food Grade:
Food grade is used to refer to products that are intended for human consumption. It includes edible oils, butter, cream, milk powder and other food ingredients which can be further processed into pharmaceutical drugs.
It has a very mild odor similar to garlic or rotten eggs; it's taste is slightly sweet with no bitter aftertaste.
Application Insights:
Neohespiridine finds application in various fields such as food, medicine, chemical, cosmetics and other. The food application segment accounted for the largest revenue share of over 40% in 2017. Neohespiridyl-based products are used as preservatives in several foods including cheese and dairy products to maintain product quality and safety.
The presence of stringent regulatory standards related to drug approval by the U.S FDA has resulted in a decline in new drug development projects involving hesperidin analogs or pure hesperidin since 2010 owing to its lack of activity against COX-2 at high concentration levels (above 100 micromolar).
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market with a CAGR of XX% from 2018 to 2030 owing to increasing demand for hespidines in China and India on account of rising incidence of diseases such as cancer, diabetes, and cardiovascular disorders. In addition, growing pharmaceutical industry coupled with government initiatives for manufacturing drugs in the region will drive product demand over the forecast period.
North America was estimated as the second-largest regional market after Asia Pacific in 2017 due to high prevalence of chronic diseases such as cancer and diabetes which are majorly treated by chemotherapy drugs. Moreover, presence of large number pharmaceutical companies that are engaged in R&D activities will fuel product growth over the forecast period. However, stringent regulatory framework regarding manufacturing hespidines may pose a challenge for North American manufacturers operating under Good Laboratory Practices (GLP) guidelines set by Organization for Economic Co-operation & Development (OECD).
Growth Factors:
- Increasing demand for natural products in the pharmaceutical and cosmetic industries
- Growing awareness of the benefits of Neohespiridine among consumers
- Rising investment in research and development for new applications of Neohespiridine
- Expansion of distribution channels to reach a wider customer base
- Growing popularity of Neohespiridine as an ingredient in dietary supplements
Scope Of The Report
Report Attributes
Report Details
Report Title
Neohespiridine Market Research Report
By Type
Industrial Grade, Food Grade, Pharmacy Grade
By Application
Food, Medicine, Chemical, Cosmetics, Other
By Companies
DuPont, Changsha Sunnycare, Biospringer, Gelfix, CP Kelco, Kang Biotech, BASF SE, Bordas Distillations Chinchurreta, Golden Health, Cargill, Okay Pharmaceutical, FMC Health and Nutrition, Nutrafur, Chr.Hansen Holding A/S, Layn, Corbion NV, Hanfang, Lianyuan Kangbiotech, Firmenich SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Neohespiridine Market Report Segments:
The global Neohespiridine market is segmented on the basis of:
Types
Industrial Grade, Food Grade, Pharmacy Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food, Medicine, Chemical, Cosmetics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DuPont
- Changsha Sunnycare
- Biospringer
- Gelfix
- CP Kelco
- Kang Biotech
- BASF SE
- Bordas Distillations Chinchurreta
- Golden Health
- Cargill
- Okay Pharmaceutical
- FMC Health and Nutrition
- Nutrafur
- Chr.Hansen Holding A/S
- Layn
- Corbion NV
- Hanfang
- Lianyuan Kangbiotech
- Firmenich SA
Highlights of The Neohespiridine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Industrial Grade
- Food Grade
- Pharmacy Grade
- By Application:
- Food
- Medicine
- Chemical
- Cosmetics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neohespiridine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neohespiridine is a medication used to treat pain. It works by blocking the action of certain chemicals in the body that can cause pain.
Some of the major companies in the neohespiridine market are DuPont, Changsha Sunnycare, Biospringer, Gelfix, CP Kelco, Kang Biotech, BASF SE, Bordas Distillations Chinchurreta, Golden Health, Cargill, Okay Pharmaceutical, FMC Health and Nutrition, Nutrafur, Chr.Hansen Holding A/S, Layn, Corbion NV, Hanfang, Lianyuan Kangbiotech, Firmenich SA.
The neohespiridine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neohespiridine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neohespiridine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neohespiridine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neohespiridine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neohespiridine Market Size & Forecast, 2018-2028
4.5.1 Neohespiridine Market Size and Y-o-Y Growth
4.5.2 Neohespiridine Market Absolute $ Opportunity
Chapter 5 Global Neohespiridine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neohespiridine Market Size Forecast by Type
5.2.1 Industrial Grade
5.2.2 Food Grade
5.2.3 Pharmacy Grade
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neohespiridine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neohespiridine Market Size Forecast by Applications
6.2.1 Food
6.2.2 Medicine
6.2.3 Chemical
6.2.4 Cosmetics
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neohespiridine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neohespiridine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neohespiridine Analysis and Forecast
9.1 Introduction
9.2 North America Neohespiridine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neohespiridine Market Size Forecast by Type
9.6.1 Industrial Grade
9.6.2 Food Grade
9.6.3 Pharmacy Grade
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neohespiridine Market Size Forecast by Applications
9.10.1 Food
9.10.2 Medicine
9.10.3 Chemical
9.10.4 Cosmetics
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neohespiridine Analysis and Forecast
10.1 Introduction
10.2 Europe Neohespiridine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neohespiridine Market Size Forecast by Type
10.6.1 Industrial Grade
10.6.2 Food Grade
10.6.3 Pharmacy Grade
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neohespiridine Market Size Forecast by Applications
10.10.1 Food
10.10.2 Medicine
10.10.3 Chemical
10.10.4 Cosmetics
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neohespiridine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neohespiridine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neohespiridine Market Size Forecast by Type
11.6.1 Industrial Grade
11.6.2 Food Grade
11.6.3 Pharmacy Grade
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neohespiridine Market Size Forecast by Applications
11.10.1 Food
11.10.2 Medicine
11.10.3 Chemical
11.10.4 Cosmetics
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neohespiridine Analysis and Forecast
12.1 Introduction
12.2 Latin America Neohespiridine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neohespiridine Market Size Forecast by Type
12.6.1 Industrial Grade
12.6.2 Food Grade
12.6.3 Pharmacy Grade
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neohespiridine Market Size Forecast by Applications
12.10.1 Food
12.10.2 Medicine
12.10.3 Chemical
12.10.4 Cosmetics
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neohespiridine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neohespiridine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neohespiridine Market Size Forecast by Type
13.6.1 Industrial Grade
13.6.2 Food Grade
13.6.3 Pharmacy Grade
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neohespiridine Market Size Forecast by Applications
13.10.1 Food
13.10.2 Medicine
13.10.3 Chemical
13.10.4 Cosmetics
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neohespiridine Market: Competitive Dashboard
14.2 Global Neohespiridine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 DuPont
14.3.2 Changsha Sunnycare
14.3.3 Biospringer
14.3.4 Gelfix
14.3.5 CP Kelco
14.3.6 Kang Biotech
14.3.7 BASF SE
14.3.8 Bordas Distillations Chinchurreta
14.3.9 Golden Health
14.3.10 Cargill
14.3.11 Okay Pharmaceutical
14.3.12 FMC Health and Nutrition
14.3.13 Nutrafur
14.3.14 Chr.Hansen Holding A/S
14.3.15 Layn
14.3.16 Corbion NV
14.3.17 Hanfang
14.3.18 Lianyuan Kangbiotech
14.3.19 Firmenich SA
